Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Data 1 from Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma
  1. Home
  2. Publications
  3. Supplementary Data 1 from Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma

Supplementary Data 1 from Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma

Authors:
  • BLBachchu Lal
    Bachchu Lal
  • AKAditya Kulkarni
    Aditya Kulkarni
  • JMJoseph McDermott
    Joseph McDermott
  • RRRana Rais
    Rana Rais
  • JAJesse Alt
    Jesse Alt
  • YWYing Wu
    Ying Wu
  • HLHernando Lopez-Bertoni
    Hernando Lopez-Bertoni
  • SSSophie Sall
    Sophie Sall
  • UKUmesh Kathad
    Umesh Kathad
  • JZJianli Zhou
    Jianli Zhou
  • BSBarbara S. Slusher
    Barbara S. Slusher
  • KBKishor Bhatia
    Kishor Bhatia

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30710363
Abstract
No abstract available
Keywords
  • CHEMOTHERAPY
  • BIOCHEMICAL MODULATORS OF THE THERAPEUTIC INDEX
  • CNS CANCERS
  • GLIOMAS, GLIOBLASTOMAS
  • SMALL MOLECULE AGENTS
  • ALKYLATING AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.